IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex

Alexander J. Valvezan(Rutgers, The State University of New Jersey), Brendan D. Manning(Harvard University)
JCI Insight
April 8, 2020
Cited by 38


Related Papers